Target intelligence / Profile preview

Candida albicans surface adhesin and cell-wall antigens

Molecular classification
Glycoprotein, Adhesin, Enzyme, Receptor, Other
01

Overview

Candida albicans surface adhesin and cell-wall antigens represent a diverse group of glycoproteins and proteins essential for the pathogenicity and structural integrity of this opportunistic fungal pathogen. Key members include the Agglutinin-like sequence (Als) family, particularly Als3, and Hyphal wall protein 1 (Hwp1), which mediate the initial attachment of the fungus to host epithelial and endothelial cells as well as abiotic surfaces like medical implants. These antigens are critical for biofilm formation, tissue invasion, and the transition from yeast to hyphal forms, which is a hallmark of virulence. In the context of drug development, these surface components are primary targets for vaccines and immunotherapies, such as the NDV-3A vaccine, which aims to elicit protective T-cell and B-cell responses to prevent recurrent infections. By targeting these antigens, therapeutic strategies seek to inhibit fungal colonization, neutralize virulence factors, and enhance opsonophagocytic killing by the host immune system.

Other names
Candida albicans cell wall proteinsC. albicans adhesinsCandida surface antigensFungal cell wall glycoproteinsAgglutinin-like sequence proteinsHyphal wall proteinsAls3Hwp1Hyr1Mannan antigens
02

Mechanism of action

Induction of neutralizing and opsonizing antibodies; inhibition of fungal adhesion to host tissues; blockade of hyphal elongation and tissue invasion; enhancement of macrophage and neutrophil-mediated phagocytosis.

03

Biological functions

Cell adhesionBiofilm formationTissue invasionImmune evasionCell wall integrityMorphogenesis (Yeast-to-hypha transition)Iron acquisition
04

Disease associations

InfectionCandidiasis (Oral, Vaginal, Systemic)SepsisBiofilm-associated infections
05

Safety considerations

Potential cross-reactivity with host proteins (e.g., moonlighting enzymes)Immune-mediated inflammatory responsesImpact on the commensal mycobiomeTherapeutic resistance through antigenic variation
06

Interacting drugs

NDV-3A (Als3p-N vaccine)

5 more in the full profile.

07

Biomarkers

Anti-Als3 antibody titerSerum mannan (Platelia Candida assay)1,3-beta-D-glucan (Fungitell assay)Anti-mannan antibodiesCandida albicans germ tube antibody (CAGTA)

Beyond the preview

Go deeper on Candida albicans surface adhesin and cell-wall antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida albicans surface adhesin and cell-wall antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call